Zusammenfassung
Der Anteil ungewollt kinderloser Ehepaare wurde 1988 für die Bundesrepublik Deutschland auf ca. 600000 geschätzt. Weltweit haben etwa 50–80 Mio. Menschen eine eingeschränkte Fertilität. Die Weltgesundheitsorganisation WHO rechnet mit ca. 2 Mio. neuen infertilen Paaren pro Jahr. Sterilität besteht definitionsgemäß erst dann, wenn trotz ungeschütztem Geschlechtsverkehr eine Schwangerschaft nach 1 bzw. 2 Jahren nicht eingetreten ist. Dabei liegt in je ca. 40 % ein männlicher bzw. weiblicher, und in ca. 20 % ein kombinierter Sterilitätsfaktor vor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur zu Kapitel 53
Bentivoglio G, Melica F, Cristoforoni P (1993) Folinic acid in the treatment of human male infertility. Fertil Steril 60: 698–701
Blackwell RE (1992) Hyperprolactinemia. Evaluation and Management. Endocrinol Metab Clin North Am 21:105–124
Bostofte E, Bagger P, Michael A, Stakemann G (1993) Fertility prognosis for infertile couples. Fertil Steril 59: 102–107
Brähler E, Felder H, Strauß B (2000) Fruchtbarkeitsstörungen — Jahrbuch der Medizinischen Psychologie. Hogrefe. Göttingen, Bern, Toronto, Seattle
Bruckert E (1991) Wie häufig ist ungewollte Kinderlosigkeit? Andrologia 23: 245–250
Buch JP, Zorn PH (1993) Evaluation and treatment of infertility in spinal cord injured men through rectal probe electroejaculation. J Urol 149:1350–1354
Carani C, Granata ARM, Faustini M, Marrama P (1996) Prolactin and testosterone: their role in male sexual function. Int J Androl 19: 48–54
Chung PH, Palermo G, Schlegel PN, Veeck LL, Eid JF, Rosen-waks Z (1998) The use of intracytoplasmic sperm injection with electroejaculates from anejaculatory men. Hum Reprod 13:1854–1858
Comhaire F, Milingos S, Liapi A et al. (1995) The effective cumulative pregnancy rate of different modes of treatment of male infertility. Andrologia 27: 217–221
Daudin M, Bieth E, Bujan L, Massat G, Pontonnier F, Mieusset R (2000) Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril 74:1164–1174
Denil J, Ohl DA, McGuire EJ, Jonas U (1992) Treatment of anejaculation with electroejaculation. Acta Urol Belg 60: 15–25
ESHRE Capri Workshop (1996) Infertility revisited: The state of the art today and tomorrow. Hum Reprod 11:1779–1807
Esterhuizen AD, Franken DR, Lourens JGH, Prinsloo E, Rooyen van LH (2000) Sperm chromatin packaging as an indicator of in-vitro fertilization rates. Hum Reprod 15: 657–661
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151:54–61
Fenster L, Katz DF, Wyrobek AJ, Pieper C, Rempel DM, Oman D, Swan SH (1997) Effects of psychological stress on human semen quality. J Androl 18:194–202
Ferlin A, Moro E, Garolla A, Foresta C (1999) Human male infertility and Y chromosome deletions: role of the AZF-candidate genes DAZ, RBM, DFFRY. Hum Reprod 14:1710–1716
Fisher MA (1993) Chlamydia trachomatis genital infection. W Va Med J 89:331–334
Glander HJ, Kratzsch J (1997) Effects of pure human follicle-stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotrophin-releas-ing hormone (GnRH). Andrologia 29: 23–28
Gleicher N (1998) Autoantibodies in infertility: current opinion. Hum Reprod Update 4:169–176
Grundy CE, Robinson J, Gordon AG, Hay DM (1991) Selection of an antibodyfree population of spermatoza from semen samples of men suffering from immunological interfility. Hum Reprod 6:593–596
Haidl G, Schill WB (1993) Moderne Diagnostik in der Andrologie. Dt Ärztebl 90: C182–C189
Hauck EW, Heitz M, Schreiter F, Weidner W (1999) Induratio penis plastica. Akt Urol 30:386–404
Hellstrom WJG, Bivalacqua TJ (2000) Peyronie’s disease: etiology, medical, and surgical therapy. J Androl 21:347–354
Henkel R, Müller C, Miska W, Gips H, Schill WB (1993) Determination of the acrosome reaction in human spermatozoa is predictive of fertilization in vitro. Hum Reprod 8: 2128–2132
Hofmann N, Kuwert E (1979) Die chronische, nicht Erregerbedingte Orchitis. Z Hautkr 54:173–180
Jeyendran RS (2000) Interpretation of semen analysis results. Cambridge University Press, Cambridge, New York, Oakleigh, Madrid, Cape Town
Jonge CJ de, Tarchala SM, Rawlins RG et al. (1993) Acrosin activity in human spermatozoa in relation to semen quality and in vitro fertilization. Hum Reprod 8: 253–257
Kamischke A, Nieschlag E (1999) Analysis of medical treatment of male infertility. Hum Reprod 14 [Suppl 1]: 1–23
Kamischke A, Nieschlag E (2000) Varicocele treatment in the light of evidence-based andrology. Hum Reprod Update 7:1–5
Kamischke A, Gromoll J, Simoni M, Behre HM, Nieschlag E (1999) Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDYi) genes from father to son through intracytoplasmic sperm injection: case report. Hum Reprod 14: 2320–2322
Kaufman JM, Vermeulen A (1997) Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11: 289–309
Köhn FM, Haidl G, Schill WB (1991) Impotentia coeundi: Diagnostik und Therapie. Z Hautkr 66:1026–1034
Köhn FM, Schill WB (1991) Die Hodensonographie und transrektale Prostata- und Bläschendrüsensonographie in der andrologischen Diagnostik. Dt Derm 39:420–431
Köhn FM, Schill WB (1998) Induktion und Nachweis der akrosomalen Reaktion menschlicher Spermatozoen. Reproduktionsmedizin 14:3–17
Köhn FM, Schill WB (1998) Iatrogene Einflüsse auf die männlichen Fertilität-Medikamente. Fertilität 13 [Suppl 1]: 31–33
Köhn FM, Haidl G, Schill WB (1999) Medikamentöse Therapie bei männlichen Fertilitätsstörungen und Hypogonadisms. Reproduktionsmedizin 15:9–17
Köhn FM, Schill WB (2000) Andrological Approach in Assisted Reproduction. In: Rabe T, Diedrich K, Strowitzki T (eds) Manual on assisted reproduction. Springer, Berlin Heidelberg New York, pp 223–287
Kolb BA, Stanczyk FZ, Sokol RZ (2000) Serum inhibin B levels in males with gonadal dyfunction. Fertil Steril 74: 234–238
Krause W, Weidner W (1998) Andrologie. Krankheiten der männlichen Geschlechtsorgane. Ferdinand Enke, Stuttgart
Land JA, Courtar DA, Evers JLH (1997) Patient dropout in an assisted reproductive technology program: implications for pregnancy rates. Fertil Steril 68: 278–281
Lee KO, Chua DJY, Cheah JS (1990) Oestrogen and progesterone receptors in men with bilateral or unilateral pubertal macromastia. Clin Endocrinol 32:101–105
Liow SL, Yong EY, Ng SC (2001) Prognostic value of Y deletion analysis. Hum Reprod 16:9–12
Lue TF (2000) Erectile dysfunction. N Engl J Med 342: 1802–1813
Mahmoud A, Comhaire F (2000) Antisperm antibodies. Hum Reprod 15: 231–233
Meschede D, Horst J (1997) The molecular genetics of male infertility. Mol Hum Reprod 3:419–430
Meschede D, Behre HM, Nieschlag E, Horst J (1994) Kallmann-Syndrom. Pathophysiologie und Klinik. Dtsch Med Wochenschr 119:1436–1442
Muller CH (2000) Rationale, interpretation, validation, and uses of sperm function tests. J Androl 21:10–30
Nieschlag E, Behre HM (1996) Andrologie. Springer, Berlin Heidelberg New York
Nieschlag E (1999) Indikation und Durchführung einer Testosterontherapie beim alternden Mann. Reproduktionsmedizin 15:96–99
Nieschlag E, Behre HM (1998) Testosterone. Action. Deficiency. Substitution. Springer, Berlin Heidelberg New York
Nikolettos N, Al-Hasami S, Baukloh V et al. (1999) The outcome of intracytoplasmic sperm injection in patients with retrograde ejaculation. Hum Reprod 14: 2293–2296
Ochsendorf F, Beschmann HA (1996) Männliche Infertilität. Springer, Berlin, Heidelberg, New York
Phillipson GTM, Petrucco OM, Matthews CD (2000) Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection. Hum Reprod 15: 431–435
Porst H (2000) Manual der Impotenz. UNI-MED, Bremen
Purvis K, Christiansen E (1993) Infection in the male reproductive tract. Impact, diagnosis and treatment in relation to male infertility. Int J Androl 16:1–13
Reiter WJ, Pycha A, Schatzl G, Pokorny A, Gruber DM, Huber JC, Marberger M (1999) Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology 53:590–594
Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ (1993) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge University Press, Cambridge, New York, Melbourne
Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA (2000) WHO manual for the standardized investigation, diagnosis and managment of the infertile male. Cambridge University Press, Cambridge, New York, Melbourne, Madrid
Schill WB, Köhn FM (1997) Spermiogramm. In: Körting HC, Sterry W (Hrsg) Diagnostische Verfahren in der Dermatologie. Blackwell, Berlin Wien, S 253–260
Schill WB, Köhn FM (1998) Andrologie. In: Altmeyer P, Dirschka T, Hartwig R (Hrsg) Klinikleitfaden Dermatologie. Gustav Fischer, Ulm Stuttgart Jena Lübeck
Schill WB, Köhn FM (1998) Andrologie. In: Fritsch P (Hrsg) Dermatologie und Venerologie. Springer, Berlin Heidelberg New York, S 757–793
Schreiber G, Kröhne HJ (1992) Hochgradige Oligozoospermie bei inkompletter Androgenresistenz. Dermatol Monatsschr 178:506–511
Schreiber G, Schambach H (1991) Männlicher Hypogonadisms und Gynäkomastie. Z Ärztl Fortbild 85:165–170
Schreiber G, Börner A, Lauterbach H, Thiel W (1983) Prolaktin und männliche Fertilität. Z Ges Inn Med 38:143–149
Schroeder-Printzen I, Köhn FM, Ludwig M, Weidner W (1996) Mikrochirurgische Epididymale Spermatozoen Aspiration (MESA) und Testikuläre Spermatozoen Extraktion (TESE). Akt Urol 27:I–VI
Stief CG, Hartmann U, Höfner K, Jonas U (1997) Erektile Dysfunktion. Springer, Berlin Heidelberg New York
Suleiman SA, Elamin Ali M, Zaki ZMS, El-Malik MA, Nasr MA (1996) Lipid peroxidation and human sperm motility: protective role of vitmanin E. J Androl 17:530–537
Tournaye H, Liu J, Nagy PZ et al. (1997) Correlation between testicular histology and outcome after intracytoplasmic sperm injection using testicular spermatozoa. Hum Reprod 11:127–132
Ven van der K, Messer L, Ven van der H, Jeyendran RS, Ober C (1996) Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod 11: 513–517
WHO (1992) A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 15: 299–307
WHO (1999) Laborhandbuch zur Untersuchung des menschlichen Ejakulates und der Spermien-Zervikalschleim-In-teraktion, 3. Aufl. Springer, Berlin Heidelberg New York
Witt MA, Grantmyre JE (1993) Ejaculatory failure. World J Urol 11: 89–95
Wong PYD (1998) CFTR gene and male infertility. Mol Hum Reprod 4:107–110
Yavetz H, Levy R, Papo J, Yogev L, Paz G, Jaffa AJ, Homonnai ZT (1992) Efficacy of varicocele embolization versus ligation of the left internal spermatic vein for improvement of sperm quality. Int J Androl 15:338–344
Zucchini S, Tacconi M, Cacciari E (1992) Cryptorchidism. Pediatr Med Chir 14:369–374
Zumbusch R, Vogt HJ (1993) Hypogonadotroper Hypogonadisms unter pulsatiler GnRH-Therapie. Hautarzt 44: 46–48
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (2002). Andrologische Störungen. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_53
Download citation
DOI: https://doi.org/10.1007/978-3-642-56219-8_53
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62541-1
Online ISBN: 978-3-642-56219-8
eBook Packages: Springer Book Archive